Hot Financial Stocks To Own For 2022

tags:LVS,BPMX,HTY,

There is considerable talk today about leaving America, and the head count is up. Of course, the numbers are still small compared to those who are arriving. And despite the rhetoric, it is rarely political. Some of it is about family, and about the pressures of America’s global tax reporting and compliance regime, including FATCA (the Foreign Account Tax Compliance Act).

Giving up a U.S. passport is not to be taken lightly, nor is giving up a long term (8 years or more) green card. For some, there is even an IRS tax on your exit. You pay tax on all your income every year. The Exit Tax is like an estate tax on the gain in your assets, even though you are not actually selling anything. It is the IRS’s last chance to tax you.

Shutterstock

The Exit Tax is computed as if you sold all your assets on the day before you expatriated, and had to report the gain.  Currently, net capital gains can be taxed as high as 23.8%, including the net investment income tax. For a time, Congress talked of hiking the tax to 30% after Eduardo Saverin of Facebook fame took off for Singapore. Still, 23.8% is nothing to sneeze at. There are three triggers for the Exit Tax, and any one of them will make you a “covered expatriate.”

Hot Financial Stocks To Own For 2022: Las Vegas Sands Corp.(LVS)

Las Vegas Sands Corp. ("LVSC," or together with its subsidiaries "we" or the "Company") is a Fortune 500 company and the leading global developer of destination properties (integrated resorts) that feature premium accommodations, world-class gaming, entertainment and retail, convention and exhibition facilities, celebrity chef restaurants and other amenities. We currently own and operate integrated resorts in Asia and the United States. We believe that our geographic diversity, best-in-class properties and convention-based business model provide us with the best platform in the hospitality and gaming industry to continue generating substantial cash flow while simultaneously pursuing new development opportunities. Our unique convention-based marketing strategy allows us to attract business travelers during the slower mid-week periods while leisure travelers occupy our properties during the weekends.   Advisors' Opinion:

• [By ]

  The casino REIT has been on an acquisition tear in the COVID-19 era, most recently scooping up MGM Growth Properties (MGP) for $17.2 billion. The move followed VICI's March purchase of the Venetian Resort Las Vegas from Las Vegas Sands (LVS) for $4 billion.

• [By Chris Lau]

  Chevrolet’s Bold next year is likewise getting good reviews from critics. Strong EV sales will lead to GM raising next year’s forecasts.

  Las Vegas Sands (LVS) Source: Andy Borysowski / Shutterstock.com

  Casino stocks slumped over the past few months, with Las Vegas Sands leading the decliners. As tourism recovers, people will visit casinos and stay at Las Vegas Sands’s resorts.

• [By ]

  Casino owner Las Vegas Sands (NYSE: LVS) was one of those, returning $2.4 billion in house winnings (or $2.75 per share). Department store owner Dillards (NYSE: DDS) made a generous payment of $5.00 per share. These were just two of dozens to make special distributions during that 60-day span totaling $14.6 billion.

• [By Motley Fool Transcription]

  LAS VEGAS SANDS CORP  (NYSE:LVS)Q1 2019 Earnings CallApril 17, 2019, 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Hot Financial Stocks To Own For 2022: BioPharmX Corporation(BPMX)

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health, dermatology, and otolaryngology markets. The company offers prescription, over-the-counter (OTC), and supplement products in oral, topical, inhalant, and/or injectable forms. It provides VI2OLET iodine, an OTC dietary supplement molecular iodine tablet that promotes overall breast health and for the alleviation of benign breast pain associated with fibrocystic breast condition. The company's clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a non-lipophilic topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician's practices, including OB-Gyn's, dermatologists, and general practioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.

Advisors' Opinion:

• [By Stephan Byrd]

  Shares of Biopharmx Corp (NYSEAMERICAN:BPMX) were up 4.8% during mid-day trading on Tuesday . The stock traded as high as $0.22 and last traded at $0.20. Approximately 32,497 shares were traded during trading, a decline of 100% from the average daily volume of 8,266,355 shares. The stock had previously closed at $0.21.

Hot Financial Stocks To Own For 2022: John Hancock Tax-Advantaged Global Shareholder Yield Fund(HTY)

John Hancock Tax-Advantaged Global Shareholder Yield Fund (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of total return consisting of a high level of current income and gains and long term capital appreciation. The Fund will seek to achieve favorable after-tax returns for its shareholders by seeking to minimize the federal income tax consequences on income and gains generated by the Fund. Under normal market condition, the Fund will invest at least 80% of its total assets in a diversified portfolio of dividend-paying stocks of issuers located around the world. The Fund also intends to write call options on a variety of both U.S. and non-U.S. broad-based indices. It invests in sectors, such as utilities, telecommunication services, consumer staples, financials, industrials, energy, healthcare, information technology, consumer discretionary and materials. The Fund's investment advisor is John Hancock Advisers, LLC, a wholly owned indirect subsidiary of Manulife Financial Corporation. Its sub-advisors are Epoch Investment Partners, Inc. and Analytic Investors, LLC.

Advisors' Opinion:

• [By Shane Hupp]

  John Hancock Tax-Advntgd Glbl SH Yld Fd (NYSE:HTY) declared a quarterly dividend on Thursday, August 23rd, Wall Street Journal reports. Shareholders of record on Friday, September 14th will be paid a dividend of 0.16 per share on Friday, September 28th. This represents a $0.64 annualized dividend and a yield of 7.68%. The ex-dividend date is Thursday, September 13th.